Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

The requested reference [26f48e0a126564af2b3d3316eb09e2d7b07a48ac] no longer exists in our database. It has been replaced by the current reference: [f5be37e5aff9005eb7d792df75ed9af40c868dbe]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
A Randomized Controlled Trial with block randomization. Inpatient subjects actively seeking substance abuse treatment at the Carrier Clinic who are diagnosed with a substance use disorder, including alcohol use disorder, tobacco use disorder, polysubstance use disorder, or other substance use disorder.
Epistemonikos ID: ff9888470204ecb4b7e5b27176e7f773bf4059c3
First added on: May 21, 2024